The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Glucose Monitoring (BGM) Market Outlook 2024
Synopsis
Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.
The global Blood Glucose Monitoring (BGM) market was valued at US$ 7867.3 million in 2020 and is expected to reach US$ 10810 million by the end of 2027, growing at a CAGR of 4.6% during 2021-2027.
This report focuses on Blood Glucose Monitoring (BGM) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Blood Glucose Monitoring (BGM) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Blood Glucose Monitoring (BGM) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Becton
Dickinson and Co.
Terumo Corporation
Acon Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
ARKRAY Inc.
Novo Nordisk A/S
Medtronic
Abbott Laboratories
Bayer AG
Ypsomed AG
Sanofi
Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.
The global Blood Glucose Monitoring (BGM) market was valued at US$ 7867.3 million in 2020 and is expected to reach US$ 10810 million by the end of 2027, growing at a CAGR of 4.6% during 2021-2027.
This report focuses on Blood Glucose Monitoring (BGM) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Blood Glucose Monitoring (BGM) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Blood Glucose Monitoring (BGM) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Becton
Dickinson and Co.
Terumo Corporation
Acon Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
ARKRAY Inc.
Novo Nordisk A/S
Medtronic
Abbott Laboratories
Bayer AG
Ypsomed AG
Sanofi
Index1 Blood Glucose Monitoring (BGM) Market Overview
1.1 Product Overview and Scope of Blood Glucose Monitoring (BGM)
1.2 Blood Glucose Monitoring (BGM) Segment by Type
1.2.1 Global Blood Glucose Monitoring (BGM) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Blood Glucose Meters
1.2.3 Continuous Glucose Monitoring Devices
1.2.4 Lancets
1.2.5 Blood Glucose Testing Strips
1.3 Blood Glucose Monitoring (BGM) Segment by Application
1.3.1 Global Blood Glucose Monitoring (BGM) Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Blood Glucose Monitoring (BGM) Market Size Estimates and Forecasts
1.4.1 Global Blood Glucose Monitoring (BGM) Revenue 2016-2027
1.4.2 Global Blood Glucose Monitoring (BGM) Sales 2016-2027
1.4.3 Blood Glucose Monitoring (BGM) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Blood Glucose Monitoring (BGM) Market Competition by Manufacturers
2.1 Global Blood Glucose Monitoring (BGM) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Blood Glucose Monitoring (BGM) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Blood Glucose Monitoring (BGM) Manufacturing Sites, Area Served, Product Type
2.5 Blood Glucose Monitoring (BGM) Market Competitive Situation and Trends
2.5.1 Blood Glucose Monitoring (BGM) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Blood Glucose Monitoring (BGM) Players Market Share by Revenue
2.5.3 Global Blood Glucose Monitoring (BGM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Glucose Monitoring (BGM) Retrospective Market Scenario by Region
3.1 Global Blood Glucose Monitoring (BGM) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Blood Glucose Monitoring (BGM) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Blood Glucose Monitoring (BGM) Market Facts & Figures by Country
3.3.1 North America Blood Glucose Monitoring (BGM) Sales by Country
3.3.2 North America Blood Glucose Monitoring (BGM) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Blood Glucose Monitoring (BGM) Market Facts & Figures by Country
3.4.1 Europe Blood Glucose Monitoring (BGM) Sales by Country
3.4.2 Europe Blood Glucose Monitoring (BGM) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Glucose Monitoring (BGM) Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Glucose Monitoring (BGM) Sales by Region
3.5.2 Asia Pacific Blood Glucose Monitoring (BGM) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Blood Glucose Monitoring (BGM) Market Facts & Figures by Country
3.6.1 Latin America Blood Glucose Monitoring (BGM) Sales by Country
3.6.2 Latin America Blood Glucose Monitoring (BGM) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Blood Glucose Monitoring (BGM) Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Glucose Monitoring (BGM) Sales by Country
3.7.2 Middle East and Africa Blood Glucose Monitoring (BGM) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Blood Glucose Monitoring (BGM) Historic Market Analysis by Type
4.1 Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2016-2021)
4.2 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2016-2021)
4.3 Global Blood Glucose Monitoring (BGM) Price by Type (2016-2021)
5 Global Blood Glucose Monitoring (BGM) Historic Market Analysis by Application
5.1 Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2016-2021)
5.2 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2016-2021)
5.3 Global Blood Glucose Monitoring (BGM) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Becton
6.1.1 Becton Corporation Information
6.1.2 Becton Description and Business Overview
6.1.3 Becton Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Becton Blood Glucose Monitoring (BGM) Product Portfolio
6.1.5 Becton Recent Developments/Updates
6.2 Dickinson and Co.
6.2.1 Dickinson and Co. Corporation Information
6.2.2 Dickinson and Co. Description and Business Overview
6.2.3 Dickinson and Co. Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Dickinson and Co. Blood Glucose Monitoring (BGM) Product Portfolio
6.2.5 Dickinson and Co. Recent Developments/Updates
6.3 Terumo Corporation
6.3.1 Terumo Corporation Corporation Information
6.3.2 Terumo Corporation Description and Business Overview
6.3.3 Terumo Corporation Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Terumo Corporation Blood Glucose Monitoring (BGM) Product Portfolio
6.3.5 Terumo Corporation Recent Developments/Updates
6.4 Acon Laboratories Inc.
6.4.1 Acon Laboratories Inc. Corporation Information
6.4.2 Acon Laboratories Inc. Description and Business Overview
6.4.3 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product Portfolio
6.4.5 Acon Laboratories Inc. Recent Developments/Updates
6.5 Roche Diagnostics Ltd.
6.5.1 Roche Diagnostics Ltd. Corporation Information
6.5.2 Roche Diagnostics Ltd. Description and Business Overview
6.5.3 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product Portfolio
6.5.5 Roche Diagnostics Ltd. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Blood Glucose Monitoring (BGM) Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 ARKRAY Inc.
6.6.1 ARKRAY Inc. Corporation Information
6.6.2 ARKRAY Inc. Description and Business Overview
6.6.3 ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ARKRAY Inc. Blood Glucose Monitoring (BGM) Product Portfolio
6.7.5 ARKRAY Inc. Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Corporation Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Medtronic Blood Glucose Monitoring (BGM) Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Corporation Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Abbott Laboratories Blood Glucose Monitoring (BGM) Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 Bayer AG
6.11.1 Bayer AG Corporation Information
6.11.2 Bayer AG Blood Glucose Monitoring (BGM) Description and Business Overview
6.11.3 Bayer AG Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Bayer AG Blood Glucose Monitoring (BGM) Product Portfolio
6.11.5 Bayer AG Recent Developments/Updates
6.12 Ypsomed AG
6.12.1 Ypsomed AG Corporation Information
6.12.2 Ypsomed AG Blood Glucose Monitoring (BGM) Description and Business Overview
6.12.3 Ypsomed AG Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Ypsomed AG Blood Glucose Monitoring (BGM) Product Portfolio
6.12.5 Ypsomed AG Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Blood Glucose Monitoring (BGM) Description and Business Overview
6.13.3 Sanofi Blood Glucose Monitoring (BGM) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sanofi Blood Glucose Monitoring (BGM) Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
7 Blood Glucose Monitoring (BGM) Manufacturing Cost Analysis
7.1 Blood Glucose Monitoring (BGM) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Glucose Monitoring (BGM)
7.4 Blood Glucose Monitoring (BGM) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Glucose Monitoring (BGM) Distributors List
8.3 Blood Glucose Monitoring (BGM) Customers
9 Blood Glucose Monitoring (BGM) Market Dynamics
9.1 Blood Glucose Monitoring (BGM) Industry Trends
9.2 Blood Glucose Monitoring (BGM) Growth Drivers
9.3 Blood Glucose Monitoring (BGM) Market Challenges
9.4 Blood Glucose Monitoring (BGM) Market Restraints
10 Global Market Forecast
10.1 Blood Glucose Monitoring (BGM) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Glucose Monitoring (BGM) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Blood Glucose Monitoring (BGM) by Type (2022-2027)
10.2 Blood Glucose Monitoring (BGM) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Blood Glucose Monitoring (BGM) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Blood Glucose Monitoring (BGM) by Application (2022-2027)
10.3 Blood Glucose Monitoring (BGM) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Glucose Monitoring (BGM) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Blood Glucose Monitoring (BGM) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Blood Glucose Monitoring (BGM) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Blood Glucose Monitoring (BGM) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Blood Glucose Monitoring (BGM) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Blood Glucose Monitoring (BGM) Covered in This Study
Table 5. Global Blood Glucose Monitoring (BGM) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Blood Glucose Monitoring (BGM) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Blood Glucose Monitoring (BGM) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Blood Glucose Monitoring (BGM) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Blood Glucose Monitoring (BGM) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Blood Glucose Monitoring (BGM) Manufacturing Sites and Area Served
Table 11. Manufacturers Blood Glucose Monitoring (BGM) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Glucose Monitoring (BGM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Glucose Monitoring (BGM) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Blood Glucose Monitoring (BGM) Sales by Region (2016-2021) & (K Units)
Table 16. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2016-2021)
Table 17. Global Blood Glucose Monitoring (BGM) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Blood Glucose Monitoring (BGM) Sales by Country (2016-2021) & (K Units)
Table 19. North America Blood Glucose Monitoring (BGM) Sales Market Share by Country (2016-2021)
Table 20. North America Blood Glucose Monitoring (BGM) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2016-2021)
Table 22. Europe Blood Glucose Monitoring (BGM) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Country (2016-2021)
Table 24. Europe Blood Glucose Monitoring (BGM) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Blood Glucose Monitoring (BGM) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Blood Glucose Monitoring (BGM) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Blood Glucose Monitoring (BGM) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Blood Glucose Monitoring (BGM) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Blood Glucose Monitoring (BGM) Sales Market Share by Country (2016-2021)
Table 32. Latin America Blood Glucose Monitoring (BGM) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Blood Glucose Monitoring (BGM) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Blood Glucose Monitoring (BGM) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Blood Glucose Monitoring (BGM) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2016-2021)
Table 38. Global Blood Glucose Monitoring (BGM) Sales (K Units) by Type (2016-2021)
Table 39. Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2016-2021)
Table 40. Global Blood Glucose Monitoring (BGM) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Blood Glucose Monitoring (BGM) Revenue Share by Type (2016-2021)
Table 42. Global Blood Glucose Monitoring (BGM) Price (USD/Unit) by Type (2016-2021)
Table 43. Global Blood Glucose Monitoring (BGM) Sales (K Units) by Application (2016-2021)
Table 44. Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2016-2021)
Table 45. Global Blood Glucose Monitoring (BGM) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Blood Glucose Monitoring (BGM) Revenue Share by Application (2016-2021)
Table 47. Global Blood Glucose Monitoring (BGM) Price (USD/Unit) by Application (2016-2021)
Table 48. Becton Corporation Information
Table 49. Becton Description and Business Overview
Table 50. Becton Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Becton Blood Glucose Monitoring (BGM) Product
Table 52. Becton Recent Developments/Updates
Table 53. Dickinson and Co. Corporation Information
Table 54. Dickinson and Co. Description and Business Overview
Table 55. Dickinson and Co. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Dickinson and Co. Blood Glucose Monitoring (BGM) Product
Table 57. Dickinson and Co. Recent Developments/Updates
Table 58. Terumo Corporation Corporation Information
Table 59. Terumo Corporation Description and Business Overview
Table 60. Terumo Corporation Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Terumo Corporation Blood Glucose Monitoring (BGM) Product
Table 62. Terumo Corporation Recent Developments/Updates
Table 63. Acon Laboratories Inc. Corporation Information
Table 64. Acon Laboratories Inc. Description and Business Overview
Table 65. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product
Table 67. Acon Laboratories Inc. Recent Developments/Updates
Table 68. Roche Diagnostics Ltd. Corporation Information
Table 69. Roche Diagnostics Ltd. Description and Business Overview
Table 70. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product
Table 72. Roche Diagnostics Ltd. Recent Developments/Updates
Table 73. Johnson & Johnson Corporation Information
Table 74. Johnson & Johnson Description and Business Overview
Table 75. Johnson & Johnson Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Johnson & Johnson Blood Glucose Monitoring (BGM) Product
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. ARKRAY Inc. Corporation Information
Table 79. ARKRAY Inc. Description and Business Overview
Table 80. ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. ARKRAY Inc. Blood Glucose Monitoring (BGM) Product
Table 82. ARKRAY Inc. Recent Developments/Updates
Table 83. Novo Nordisk A/S Corporation Information
Table 84. Novo Nordisk A/S Description and Business Overview
Table 85. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product
Table 87. Novo Nordisk A/S Recent Developments/Updates
Table 88. Medtronic Corporation Information
Table 89. Medtronic Description and Business Overview
Table 90. Medtronic Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Medtronic Blood Glucose Monitoring (BGM) Product
Table 92. Medtronic Recent Developments/Updates
Table 93. Abbott Laboratories Corporation Information
Table 94. Abbott Laboratories Description and Business Overview
Table 95. Abbott Laboratories Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Abbott Laboratories Blood Glucose Monitoring (BGM) Product
Table 97. Abbott Laboratories Recent Developments/Updates
Table 98. Bayer AG Corporation Information
Table 99. Bayer AG Description and Business Overview
Table 100. Bayer AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Bayer AG Blood Glucose Monitoring (BGM) Product
Table 102. Bayer AG Recent Developments/Updates
Table 103. Ypsomed AG Corporation Information
Table 104. Ypsomed AG Description and Business Overview
Table 105. Ypsomed AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Ypsomed AG Blood Glucose Monitoring (BGM) Product
Table 107. Ypsomed AG Recent Developments/Updates
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Sanofi Blood Glucose Monitoring (BGM) Product
Table 112. Sanofi Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Blood Glucose Monitoring (BGM) Distributors List
Table 116. Blood Glucose Monitoring (BGM) Customers List
Table 117. Blood Glucose Monitoring (BGM) Market Trends
Table 118. Blood Glucose Monitoring (BGM) Growth Drivers
Table 119. Blood Glucose Monitoring (BGM) Market Challenges
Table 120. Blood Glucose Monitoring (BGM) Market Restraints
Table 121. Global Blood Glucose Monitoring (BGM) Sales Forecast by Type (2022-2027) & (K Units)
Table 122. Global Blood Glucose Monitoring (BGM) Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Blood Glucose Monitoring (BGM) Sales Forecast by Application (2022-2027) & (K Units)
Table 126. Global Blood Glucose Monitoring (BGM) Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Blood Glucose Monitoring (BGM) Sales Forecast by Region (2022-2027) & (K Units)
Table 130. Global Blood Glucose Monitoring (BGM) Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Glucose Monitoring (BGM)
Figure 2. Global Blood Glucose Monitoring (BGM) Market Share by Type in 2020 & 2027
Figure 3. Blood Glucose Meters Product Picture
Figure 4. Continuous Glucose Monitoring Devices Product Picture
Figure 5. Lancets Product Picture
Figure 6. Blood Glucose Testing Strips Product Picture
Figure 7. Global Blood Glucose Monitoring (BGM) Market Share by Application in 2020 & 2027
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Household
Figure 11. Other
Figure 12. Global Blood Glucose Monitoring (BGM) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Blood Glucose Monitoring (BGM) Market Size 2016-2027 (US$ Million)
Figure 14. Global Blood Glucose Monitoring (BGM) Sales 2016-2027 (K Units)
Figure 15. Global Blood Glucose Monitoring (BGM) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Blood Glucose Monitoring (BGM) Sales Share by Manufacturers in 2020
Figure 17. Global Blood Glucose Monitoring (BGM) Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Blood Glucose Monitoring (BGM) Players: Market Share by Revenue in 2020
Figure 19. Blood Glucose Monitoring (BGM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2016-2021)
Figure 21. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region in 2020
Figure 22. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2016-2021)
Figure 23. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region in 2020
Figure 24. U.S. Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Blood Glucose Monitoring (BGM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Blood Glucose Monitoring (BGM) by Type (2016-2021)
Figure 49. Sales Market Share of Blood Glucose Monitoring (BGM) by Application (2016-2021)
Figure 50. Sales Market Share of Blood Glucose Monitoring (BGM) by Application in 2020
Figure 51. Revenue Share of Blood Glucose Monitoring (BGM) by Application (2016-2021)
Figure 52. Revenue Share of Blood Glucose Monitoring (BGM) by Application in 2020
Figure 53. Manufacturing Cost Structure of Blood Glucose Monitoring (BGM)
Figure 54. Manufacturing Process Analysis of Blood Glucose Monitoring (BGM)
Figure 55. Blood Glucose Monitoring (BGM) Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
